UNTREATED ADULT ACUTE LYMPHOBLASTIC LEUKEMIA

Clinical trials for UNTREATED ADULT ACUTE LYMPHOBLASTIC LEUKEMIA explained in plain language.

Never miss a new study

Get alerted when new UNTREATED ADULT ACUTE LYMPHOBLASTIC LEUKEMIA trials appear

Sign up with your email to follow new studies for UNTREATED ADULT ACUTE LYMPHOBLASTIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New drug combo tested for Tough-to-Treat leukemia

Disease control Ongoing

This study is testing a combination of intensive chemotherapy (called Hyper-CVAD) and a targeted drug called ponatinib for adults with a specific type of acute lymphoblastic leukemia (ALL) that involves a genetic change called Philadelphia chromosome or BCR-ABL. The main goal is …

Matched conditions: UNTREATED ADULT ACUTE LYMPHOBLASTIC LEUKEMIA

Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated Mar 23, 2026 15:15 UTC

UNTREATED ADULT ACUTE LYMPHOBLASTIC LEUKEMIA

Get alerted when new UNTREATED ADULT ACUTE LYMPHOBLASTIC LEUKEMIA trials appear

New drug combo tested for Tough-to-Treat leukemia